Bone health in professional cycling

HAN University of Applied Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

ot applicable

•Inclusion criteria
•World tour level (highest level) professional male cyclists (aged 22 – 40):
•Professional cyclist competing in UCI’s WorldTour competition
•Willing to give written informed consent.
•Willing to comply with study procedures.
•Accept use of all encoded data, including publication, and the confidential use and storage of all data for 15 years.
•World tour level professional female cyclists (aged 22 – 40):
•Professional cyclist competing in UCI’s Women’s WorldTour competition
•Willing to give written informed consent.
•Willing to comply with study procedures.
•Accept use of all encoded data, including publication, and the confidential use and storage of all data for 15 years.
•Talented elite male cyclist (aged 18 – 22):
•Included in a talent program of professional cycling team
•Willing to give written informed consent.
•Willing to comply with study procedures.
•Accept use of all encoded data, including publication, and the confidential use and storage of all data for 15 years.
•Retired world tour level professional cyclists (aged 35 – 60):
•Retired male of female professional cyclist.
•A minimum of 5 years of professional cycling at WorldTour level.
•Duration of retirement is minimal 1 year before Day 01 of this study.
•Willing to give written informed consent.
•Willing to comply with study procedures.
•Accept use of all encoded data, including publication, and the confidential use and storage of all data for 15 years.

•Exclusion criteria
•Having a history of medical events or medication use that may significantly affect bone metabolism, to be decided by the principal investigator.
•Medication use that may affect tests within this study must be minimal 3 months before Day 01 of this study.
•Participation in any clinical trial including blood sampling and/or administration of substances up to 30 days before Day 01 of this study
•A recent injury that may significantly affect BMD, to be decided by the principal investigator.

发起方